![poly adp-ribose polymerase (parp) inhibitor market](https://goodprnews.com/wp-content/uploads/2024/06/Poly-ADP-Ribose-Polymerase-PARP-Inhibitor-Market-348x215.jpg)
Poly ADP-Ribose Polymerase (PARP) Inhibitor Global Market By Drug Type, By Application, By Distribution Channel, By Regional Forecast 2024-2033 | Pfizer Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A.
Overview and Scope Poly ADP-ribose polymerase (PARP) inhibitors are a class of pharmacological inhibitors that block the enzyme PARP, which is involved in deoxyribonucleic acid (DNA) repair. These inhibitors treat …
Poly ADP-Ribose Polymerase (PARP) Inhibitor Global Market By Drug Type, By Application, By Distribution Channel, By Regional Forecast 2024-2033 | Pfizer Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A. Read More